Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2022

Open Access 01-12-2022 | Systemic Lupus Erythematosus | Case report

Liver infarctions as the first manifestation of antiphospholipid antibody syndrome in pregnancy: a case report

Authors: Claudia Meloni, Cornelia Schreiber, Jan-Dirk Studt, Simone Kamm, Manuela Di Chiara, Thomas Herren

Published in: Journal of Medical Case Reports | Issue 1/2022

Login to get access

Abstract

Background

The differential diagnosis of abdominal pain in pregnant women is broad. Liver diseases as the origin of abdominal pain in pregnancy are rare, and severe forms occur in less than 0.1% of pregnancies. Some disorders, such as hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome and preeclampsia, are unique to pregnancy, while others, such as antiphospholipid antibody syndrome, may manifest in pregnancy but have consequences beyond the current pregnancy. All of them require prompt identification and treatment.

Case presentation

A 27-year-old Caucasian woman who was 15+1 weeks pregnant reported to the emergency department twice due to stabbing right-upper-quadrant abdominal pain. Initial laboratory testing revealed mild leukocytosis and slightly elevated liver enzymes. On second presentation, the patient was febrile and had an increased C-reactive protein concentration. Over the course of the next days, nonhemolytic anemia and thrombocytopenia emerged with elevated liver enzymes. Coagulation studies also revealed a prolongation of activated partial thromboplastin time. Magnetic resonance imaging showed nonspecific alterations in the right liver lobe, possibly corresponding to infection or infarction. A hepatic viral infection was ruled out. At that time, the most likely diagnosis was cholangitis with liver abscess formation, and antibiotic therapy was started. Further worsening of the anemia and thrombocytopenia, development of proteinuria, together with a miscarriage on the fourth day of hospitalization resulted in the tentative diagnosis of (triple-positive) antiphospholipid antibody syndrome, which was confirmed 12 weeks after the initial investigation. Treatment consisted of prompt anticoagulation with heparin and later on with a vitamin K antagonist as well as high-dose glucocorticoid therapy. There was no need for intravenous immunoglobulin therapy or plasma exchange, although we suspected a catastrophic form of antiphospholipid antibody syndrome due to infarctions of the liver, placenta, and possibly kidneys (proteinuria). The outcome was favorable.

Conclusion

We report a 27-year-old pregnant woman whose abdominal pain was caused by liver infarctions as the first manifestation of catastrophic antiphospholipid antibody syndrome. The antiphospholipid antibody syndrome was possibly secondary to hitherto clinically silent systemic lupus erythematosus since the antinuclear antibodies were increased later on. Hydroxychloroquine therapy was initiated to prevent antiphospholipid antibody syndrome recurrence in a future pregnancy.
Literature
1.
go back to reference Mayer IE, Hussain H. Abdominal pain during pregnancy. Gastroenterol Clin North Am. 1998;27(1):1–36.CrossRef Mayer IE, Hussain H. Abdominal pain during pregnancy. Gastroenterol Clin North Am. 1998;27(1):1–36.CrossRef
2.
go back to reference Uthman I, Khamashta M. The abdominal manifestations of the antiphospholipid syndrome. Rheumatology. 2007;46(11):1641–7.CrossRef Uthman I, Khamashta M. The abdominal manifestations of the antiphospholipid syndrome. Rheumatology. 2007;46(11):1641–7.CrossRef
3.
go back to reference Kim JH, Yee C, Kuk JY, Choi SJ, Oh SY, Roh CR, et al. Hepatic infarction in a pregnant woman with antiphospholipid syndrome and triple antibody positivity: a case report focusing on catastrophic antiphospholipid syndrome. Obstet Gynecol Sci. 2016;59(5):397–402.CrossRef Kim JH, Yee C, Kuk JY, Choi SJ, Oh SY, Roh CR, et al. Hepatic infarction in a pregnant woman with antiphospholipid syndrome and triple antibody positivity: a case report focusing on catastrophic antiphospholipid syndrome. Obstet Gynecol Sci. 2016;59(5):397–402.CrossRef
4.
go back to reference He J, Xiao ZS, Shan YH, Song J. Misdiagnosis of liver infarction after cesarean section in a patient with antiphospholipid syndrome during pregnancy. Chin Med J (Engl). 2015;128(2):282–3.CrossRef He J, Xiao ZS, Shan YH, Song J. Misdiagnosis of liver infarction after cesarean section in a patient with antiphospholipid syndrome during pregnancy. Chin Med J (Engl). 2015;128(2):282–3.CrossRef
5.
go back to reference Verlohren S, Brennecke SP, Galindo A, Karumanchi SA, Mirkovic LB, Schlembach D, et al. Clinical interpretation and implementation of the sFlt-1/PlGF ratio in the prediction, diagnosis and management of preeclampsia. Pregnancy Hypertens. 2021;27:42–50.CrossRef Verlohren S, Brennecke SP, Galindo A, Karumanchi SA, Mirkovic LB, Schlembach D, et al. Clinical interpretation and implementation of the sFlt-1/PlGF ratio in the prediction, diagnosis and management of preeclampsia. Pregnancy Hypertens. 2021;27:42–50.CrossRef
6.
go back to reference Lagana AS, Favilli A, Triolo O, Granese R, Gerli S. Early serum markers of pre-eclampsia: are we stepping forward? J Matern Fetal Neonatal Med. 2016;29(18):3019–23.CrossRef Lagana AS, Favilli A, Triolo O, Granese R, Gerli S. Early serum markers of pre-eclampsia: are we stepping forward? J Matern Fetal Neonatal Med. 2016;29(18):3019–23.CrossRef
7.
go back to reference Garcia D, Erkan D. Diagnosis and management of the antiphospholipid syndrome. N Engl J Med. 2018;378(21):2010–21.CrossRef Garcia D, Erkan D. Diagnosis and management of the antiphospholipid syndrome. N Engl J Med. 2018;378(21):2010–21.CrossRef
8.
go back to reference Miyakis S, Lockshin M, Atsumi T, Branch D, Brey R, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295–306.CrossRef Miyakis S, Lockshin M, Atsumi T, Branch D, Brey R, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295–306.CrossRef
9.
go back to reference Asherson R, Cervera R, De Groot P, Erkan D, Boffa M, Piette J, et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus. 2003;12(7):530–4.CrossRef Asherson R, Cervera R, De Groot P, Erkan D, Boffa M, Piette J, et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus. 2003;12(7):530–4.CrossRef
10.
go back to reference Cervera R, Rodríguez-Pintó I, Espinosa G. The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: a comprehensive review. J Autoimmun. 2018;92:1–11.CrossRef Cervera R, Rodríguez-Pintó I, Espinosa G. The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: a comprehensive review. J Autoimmun. 2018;92:1–11.CrossRef
11.
go back to reference Cervera R, Serrano R, Pons-Estel G, Ceberio-Hualde L, Shoenfeld Y, De Ramón E, et al. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis. 2015;74(6):1011–8.CrossRef Cervera R, Serrano R, Pons-Estel G, Ceberio-Hualde L, Shoenfeld Y, De Ramón E, et al. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis. 2015;74(6):1011–8.CrossRef
12.
go back to reference Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European league against rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019;71(9):1400–12.CrossRef Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European league against rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019;71(9):1400–12.CrossRef
13.
go back to reference Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med. 2008;358(9):929–39.CrossRef Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med. 2008;358(9):929–39.CrossRef
Metadata
Title
Liver infarctions as the first manifestation of antiphospholipid antibody syndrome in pregnancy: a case report
Authors
Claudia Meloni
Cornelia Schreiber
Jan-Dirk Studt
Simone Kamm
Manuela Di Chiara
Thomas Herren
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2022
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-022-03324-8

Other articles of this Issue 1/2022

Journal of Medical Case Reports 1/2022 Go to the issue